Skip to main content
. 2019 Mar 4;2019(3):CD007868. doi: 10.1002/14651858.CD007868.pub3

Peterson 1979.

Methods Trial design: 3‐armed, double‐blind, placebo‐controlled, stratified RCT
 Location: USA
 Number of centres: not reported. Parochial schools in Bismarck and Fargo, North Dakota
 Recruitment period: study began 1971
Participants Inclusion criteria: not reported
 Exclusion criteria: not reported
 Baseline caries: 2.9 DFS (Gp A: 3.04 (SD 3.50); Gp B: 2.85 (SD 2.92); Gp C: 2.69 (SD 2.66)). Baseline characteristics (DFS, MD‐DFS, DFT, SAR, TAR) "balanced" (evaluated participants only)
 Age at baseline (years): range 8 to 12 years, mean 10 years (Gp A: 123.88 months (SD 13.01); Gp B: 124.84 months (SD 11.94); Gp C: 124.64 months (SD 12.11)) (evaluated participants only)
 Sex: not reported
 Any other details of important prognostic factors: background exposure to fluoride: community water supply fluoridated 1.2 ppm F
 Number randomised: 950 (group distribution not reported)
 Number evaluated: 712 at 2.5 years (present for all examinations) (Gp A: 237; Gp B: 230; Gp C: 245)
 Attrition: 25% dropout after 2.5 years (study duration = 2.5 years). Natural losses; exclusions based on presence in all follow‐up examinations; any differential group losses not assessable
Interventions Comparison: FT (2 groups) versus PL
 Gp A (n = evaluated 237): SMFP 1000 ppm F; abrasive system: Ca carbonate; school use/supervised, daily (appropriate toothpastes also provided for home use)
 Gp B (n = evaluated 230): SMFP 1000 ppm F; abrasive system: IMP; school use/supervised, daily (appropriate toothpastes also provided for home use)
 Gp C (n = evaluated 245): placebo; abrasive system: Ca carbonate; school use/supervised, daily (appropriate toothpastes also provided for home use)
Outcomes Primary: 2.5‐year DFS increment ‐ cl + xr; DMFT; MD‐DFS (at 2.5 years)
 Secondary: none assessed
 Assessments irrelevant to this review's scope: n/a
 Follow‐up duration: 2.5 years
Notes Adverse effects: not reported
 Funding source: grant from manufacturer, Beecham Inc
 Declarations/conflicts of interest: not reported
 Data handling by review authors: groups A + B combined versus C in analysis
 Other information of note: clinical (VT) caries assessment (FOTI used) by 1 examiner, diagnostic threshold = CA; state of tooth eruption included not reported; radiographic assessment (postBW) by 1 examiner, diagnostic threshold = ER. Diagnostic errors not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "The children were then stratified by age and sex and assigned at random to 1 of 3 dentifrice groups"
Comment: not enough information provided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection bias) 
 All outcomes Low risk Quotes: "Except for the absence of NaMFP, this placebo formulation was identical to that of experimental dentifrice" and "The double blind technique was used, neither the examiner nor the subjects knowing to which dentifrice group they had been assigned"
Comment: blinding outcome assessment and use of placebo described
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Overall dropout for length of follow‐up: 25.1% 238/950 in 2.5 years (all groups). Dropout by group: not reported. Reasons for losses: mainly due to moving from the area, and exclusion based on presence at all examinations
Comment: numbers lost are not unduly high for length of follow‐up. It is unclear if there were any differential losses, and if reasons for missing outcome data are acceptable and balanced. Caries data used in the analysis pertain to participants present for all examinations
Selective reporting (reporting bias) Low risk Outcomes reported:
 DFS increment ‐ cl + xr, reported at 2.5 years follow‐up
 DMFT
 MD‐DFS
Comment: trial protocol not available. All pre‐specified outcomes (in Methods) were reported and were reported in the pre‐specified way
Baseline characteristics balanced? Low risk Prognostic factors reported:
 DFS: 3.04 (3.50) FT 1; 2.85 (2.92) FT 2; 2.69 (2.66) PL
age (months): 123.88 (13.01) FT 1; 124 (11.94) FT 2; 124.64 (12.11) PL
TAR: 14.49 (5.10) FT 1; 15.16 (5.35) FT 2; 14.84 (5.24) PL
DFT: 2.23 (2.16) FT 1; 2.06 (1.71) FT 2; 2.05 (1.70) PL
SAR: 79.73 (26.22) FT 1; 83.78 (27.28) FT 2; 81.53 (26.37) PL
Comment: initial caries appears balanced
Free of contamination/co‐intervention? Low risk Quote: "All subjects periodically received toothbrushes and dentifrices individually labelled for school and home use"
Comment: there is sufficient indication overall of prevention of contamination/co‐intervention